Cargando…
Co-administration of human MSC overexpressing HIF-1α increases human CD34(+) cell engraftment in vivo
BACKGROUND: Poor graft function or graft failure after allogeneic stem cell transplantation is an unmet medical need, in which mesenchymal stromal cells (MSC) constitute an attractive potential therapeutic approach. Hypoxia-inducible factor-1α (HIF-1α) overexpression in MSC (HIF-MSC) potentiates the...
Autores principales: | Preciado, Silvia, Sirerol-Piquer, Mª Salomé, Muntión, Sandra, Osugui, Lika, Martí-Chillón, Gerardo J., Navarro-Bailón, Almudena, Sepúlveda, Pilar, Sánchez-Guijo, Fermín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650423/ https://www.ncbi.nlm.nih.gov/pubmed/34876206 http://dx.doi.org/10.1186/s13287-021-02669-z |
Ejemplares similares
-
Therapeutic potential of mesenchymal stromal/stem cells in critical‐care patients with systemic inflammatory response syndrome
por: Martí‐Chillón, Gerardo‐Javier, et al.
Publicado: (2023) -
Eltrombopag increases the hematopoietic supporting ability of
mesenchymal stem/stromal cells
por: Muntión, Sandra, et al.
Publicado: (2022) -
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34(+) Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
por: Preciado, Silvia, et al.
Publicado: (2019) -
MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry
por: L. Ramos, Teresa, et al.
Publicado: (2016) -
MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients
por: López, Raúl, et al.
Publicado: (2021)